Bill Shaikin has a column up today in which one of Roger Clemens’ lawyers argues for Clemens’ induction to the Hall of Fame. Shocker, I know. But apart from him, this passage piques my interest:
Clemens is one of the headline attractions in what could be the most divisive election in Hall of Fame history. The first-time candidates include Clemens, Barry Bonds, Mike Piazza and Sammy Sosa, each of whom has been linked to performance-enhancing substances.
Clemens, Bonds and Sosa’s PED resumes are pretty well-known, but Piazza has not been publicly cast into their league. The relevant data points:
- He admitted in 2002 to using androstenedione early in his career, but andro was not banned in baseball until 2004;
- Murray Chass has gone on an unhinged one-man crusade (see here, here, here and here), saying that since he saw that Piazza had acne on his back, he had to be a ‘roider.
That’s it. That’s the alpha and omega of Piazza being “linked” to PEDs.
I don’t know if Piazza did anything besides andro. Maybe he did. Lots of star players of his generation did. Maybe that autobiography of his that comes out next February will say so. Maybe someone with actual first-hand knowledge of it will lay the evidence out for us.
But as Hall of Fame voters sit here today, all they have is legal andro use and Murray Chass’ back acne, which has been discredited by dermatologists as any sort of dispositive evidence. I have this feeling that alone is going to be enough for a huge number of Hall of Fame voters to withhold their vote for Piazza, despite him being ridiculously, over-the-top qualified for first ballot induction.
With last Wednesday’s start against the Yankees, Mariners hurler Hisashi Iwakuma pushed his 2016 innings total up to 2016. That clears the 162-inning hurdle for his 2017 option to vest at $14 million. However, as Steve Adams of MLB Trade Rumors reports, the language in Iwakuma’s contract also stipulates that the right-hander finish the season without suffering a specific injury.
Iwakuma, 35, was in agreement with the Dodgers on a three-year contract back in December but failed the physical, which nullified the deal. He ended up signing with the Mariners on a one-year, $12 million deal with a full no-trade clause and club options for 2017 and ’18 that vest at specific inning thresholds (162 each or 324 for both seasons).
This season, Iwakuma has stayed healthy, making 26 starts to the tune of a 14-9 record, a 3.81 ERA and a 118/36 K/BB ratio in 163 innings.
Marlins outfielder Ichiro Suzuki deposited a single to left-center field in the fourth inning of Monday night’s game against the Mets, then added a double to center field in the eighth. Those mark hits No. 3,010 and 3,011 for Suzuki in his major league career, tying and then moving past Wade Boggs for sole possession of 27th on baseball’s all-time hits list.
Suzuki would come around to score on a double by Xavier Scruggs to break a scoreless tie in the eighth.
Here’s the video of Ichiro’s first hit.
By the end of the season, Suzuki will have presumably moved ahead of Rafael Palmeiro (26th; 3,020) and Lou Brock (25th; 3,023).
Suzuki was 2-for-4 after the double. With baseball’s fifth month nearly complete, the 42-year-old is currently batting .298/.371/.373.